INS and diabetes mellitus: For example, despite the severity of diabetes and its possible life-threatening complications in case resulting from inadequate treatment, only 32.4%, 35.3%, and 11.8% have in stock biguanides, sulfonylureas, and insulin respectively, out of the 34 visited.